The organization applies a collaborative business model to the process of medical research with the aim of accelerating the identification and development of new patient treatments.
Under the ARC model, MRF-funded researchers in different labs design and carry out experiments together and share results in real time, thus accelerating the rate at which medical discoveries are made.
The results, called “potential drug or therapeutic targets,” are then validated, patented and licensed to a pharmaceutical partner who will take them through the clinical trials process and into a new treatment.
[9] The MRF has been profiled several times in the national media, including features in The Wall Street Journal, The San Francisco Chronicle, The New Yorker, and BusinessWeek.
It has also been used as an example in books such as The Definitive Drucker, by Elizabeth Haas Edersheim; The Culture of Collaboration, by Evan Rosen, and We Are the New Radicals, by Julia Moulden.